What if: A retrospective reconstruction of resection cavity stereotactic radiosurgery to mimic neoadjuvant stereotactic radiosurgery.
CyberKnife®
brain metastases (BM)
neoadjuvant
preoperative
stereotactic radiosurgery (SRS)
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
28
09
2022
accepted:
20
02
2023
medline:
4
4
2023
entrez:
3
4
2023
pubmed:
4
4
2023
Statut:
epublish
Résumé
Neoadjuvant stereotactic radiosurgery (NaSRS) of brain metastases has gained importance, but it is not routinely performed. While awaiting the results of prospective studies, we aimed to analyze the changes in the volume of brain metastases irradiated pre- and postoperatively and the resulting dosimetric effects on normal brain tissue (NBT). We identified patients treated with SRS at our institution to compare hypothetical preoperative gross tumor and planning target volumes (pre-GTV and pre-PTV) with original postoperative resection cavity volumes (post-GTV and post-PTV) as well as with a standardized-hypothetical PTV with 2.0 mm margin. We used Pearson correlation to assess the association between the GTV and PTV changes with the pre-GTV. A multiple linear regression analysis was established to predict the GTV change. Hypothetical planning for the selected cases was created to assess the volume effect on the NBT exposure. We performed a literature review on NaSRS and searched for ongoing prospective trials. We included 30 patients in the analysis. The pre-/post-GTV and pre-/post-PTV did not differ significantly. We observed a negative correlation between pre-GTV and GTV-change, which was also a predictor of volume change in the regression analysis, in terms of a larger volume change for a smaller pre-GTV. In total, 62.5% of cases with an enlargement greater than 5.0 cm Patients with smaller brain metastases may have a higher risk of volume increase when irradiated postoperatively. Target volume delineation is of great importance because the PTV directly affects the exposure of NBT, but it is a challenge when contouring resection cavities. Further studies should identify patients at risk of relevant volume increase to be preferably treated with NaSRS in routine practice. Ongoing clinical trials will evaluate additional benefits of NaSRS.
Identifiants
pubmed: 37007157
doi: 10.3389/fonc.2023.1056330
pmc: PMC10062706
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1056330Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2023 Acker, Nachbar, Soffried, Bodnar, Janas, Krantchev, Kalinauskaite, Kluge, Shultz, Conti, Kaul, Zips, Vajkoczy and Senger.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Neurooncol. 2014 Oct;120(1):163-9
pubmed: 25048529
Radiat Oncol. 2011 May 15;6:48
pubmed: 21575163
Radiother Oncol. 2022 Jul 26;:
pubmed: 35905780
Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1142-8
pubmed: 27209508
Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):764-771
pubmed: 31785338
Breast Cancer Res. 2012 Aug 16;14(4):R119
pubmed: 22898337
Curr Oncol Rep. 2012 Feb;14(1):48-54
pubmed: 22012633
Lancet Oncol. 2017 Aug;18(8):1040-1048
pubmed: 28687375
Front Oncol. 2022 May 16;12:873175
pubmed: 35651793
Cureus. 2016 Apr 19;8(4):e575
pubmed: 27226936
World Neurosurg. 2018 Dec;120:e480-e487
pubmed: 30149167
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):68-86
pubmed: 32921513
J Clin Oncol. 2022 Feb 10;40(5):492-516
pubmed: 34932393
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):899-906
pubmed: 24606851
Radiat Oncol. 2022 Jul 1;17(1):116
pubmed: 35778741
J Radiosurg SBRT. 2018;5(2):89-97
pubmed: 29657889
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):187-94
pubmed: 16814946
Radiat Oncol. 2020 Sep 29;15(1):225
pubmed: 32993672
J Immunother Cancer. 2021 Dec;9(12):
pubmed: 34949695
Front Oncol. 2020 May 08;10:693
pubmed: 32477942
Neuro Oncol. 2020 Aug 17;22(8):1173-1181
pubmed: 31970416
Strahlenther Onkol. 2018 Jun;194(6):560-569
pubmed: 29349605
Cancer. 2020 Oct 1;126(19):4341-4352
pubmed: 32678971
Neurosurgery. 2016 Aug;79(2):279-85
pubmed: 26528673
Clin Exp Metastasis. 2020 Apr;37(2):341-352
pubmed: 31950392
Radiother Oncol. 2016 Nov;121(2):217-224
pubmed: 27793446
Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):772-779
pubmed: 31928848
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):943-8
pubmed: 22494581
J Radiosurg SBRT. 2018;5(3):191-200
pubmed: 29988304
Cureus. 2019 Sep 25;11(9):e5762
pubmed: 31723521
Cancers (Basel). 2019 Mar 01;11(3):
pubmed: 30832257
J Neurooncol. 2017 Feb;131(3):611-618
pubmed: 28000105
Neurosurgery. 2019 Nov 1;85(5):632-641
pubmed: 30335175
Neurosurgery. 2020 Aug 1;87(2):403-407
pubmed: 31673708
Int J Radiat Oncol Biol Phys. 2021 Sep 1;111(1):68-80
pubmed: 33891979
J Neurosurg. 2018 Dec 1;:1-8
pubmed: 30554174
Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):764-772
pubmed: 34058254
Strahlenther Onkol. 2014 Jun;190(6):521-32
pubmed: 24715242
Radiother Oncol. 2016 Aug;120(2):253-7
pubmed: 27212141
Neuro Oncol. 2020 Jan 11;22(1):84-93
pubmed: 31412120
Lancet Oncol. 2015 Jun;16(6):e270-8
pubmed: 26065612
J Clin Oncol. 2011 Jan 10;29(2):134-41
pubmed: 21041710
Oper Neurosurg (Hagerstown). 2022 Apr 1;22(4):208-214
pubmed: 35234410
Lancet Oncol. 2017 Aug;18(8):1049-1060
pubmed: 28687377
Med Phys. 2010 Aug;37(8):4078-101
pubmed: 20879569
Oncotarget. 2016 Nov 8;7(45):74006-74014
pubmed: 27659537
Discov Oncol. 2021 Nov 8;12(1):48
pubmed: 35201504
Cureus. 2017 Dec 26;9(12):e1987
pubmed: 29503781
Cancer Treat Rev. 2011 Nov;37(7):567-78
pubmed: 21571440
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):336-42
pubmed: 22652105
Neurosurgery. 2013 Feb;72(2):180-5; discussion 185
pubmed: 23149969
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):537-43
pubmed: 26867883
Strahlenther Onkol. 2019 Mar;195(3):207-217
pubmed: 30386864
J Neurooncol. 2014 Dec;120(3):657-63
pubmed: 25189789
Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):436-442
pubmed: 29157748
Front Neurol. 2018 Nov 13;9:959
pubmed: 30542316
J Clin Neurosci. 2018 Mar;49:48-55
pubmed: 29248376
JAMA. 1998 Nov 4;280(17):1485-9
pubmed: 9809728
J Clin Oncol. 2022 Jul 10;40(20):2271-2276
pubmed: 35561283